Posters will be on display from Tuesday, 10 February until Thursday, 12 February.
Presenters will be in attendance to discuss their posters in this topic between 16:00-17:00 on Wednesday, 11 February.
|
Association between gene polymorphism of Presenilin 1 or Butyrylcholinesterase and Japanese alzheimer’s disease
|
|
Treatment of alzheimers disease with galantamine in a naturalistic setting: Preliminary results from the nature study
|
|
A therapeutic strategy for Alzheimer' s disease using anti-inflammatory effects of phosphatidylserine(PS)-liposomes
|
|
Frontal lobe tests in patients with Alzheimer's disease treated with donepezil or rivastigmine
|
|
Casuistics-recent findings of Alzheimers dementia -possibilities and treatment in a psychiatric outpatients department
|
|
Prevalence of mild cognitive impairment in 60 to 64 year old community-dwelling individuals: The PATH Through Life 60 + study
|
|
Quality of life in elderly patients over 65 with myocardial infarction and comorbid depression
|
|
Serum anticholinergic activity in Alzheimer's disease
|
|
Family cases of Alzheimer`s disease and immunity
|
|
Activity of Xanthine oxidase in different brain regions of patients with Alzheimner`s dementia - A post mortem study
|
|
Matrix metalloproteinases and protein 14-3-3 in Creutzfeldt-Jakob disease
|
|
Acute and chronic Celecoxib but only chronic indomethacin administration reduced electroconvulsive shock induced retrograde amnesia in rats
|
|
CSF-neurofilament levels might predict cognitive response in PD – dementia patients treated with Cholinesterase inhibitors
|
|
Association study of alpha7 gene in sporadic Alzheimer's disease
|